bibliographic entry 6351787 [be/6351787]
https://w3id.org/oc/corpus/be/6351787

is a
content
  • Ghobrial, IM, Roccaro, A, Hong, F, Weller, E, Rubin, N, Leduc, R, Rourke, M, Chuma, S, Sacco, A, Jia, X, Azab, F, Azab, AK, Rodig, S, Warren, D, Harris, B, Varticovski, L. Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia, Clin Cancer Res, 2010, 16, 1033, 1041, PMID: 20103671
references